Featured Research

from universities, journals, and other organizations

New Insight Into Heart Failure Suggests Novel Drug Target

Date:
October 2, 2003
Source:
Duke University Medical Center
Summary:
By disrupting the activity of a single heart protein, Duke University Medical Center researchers eased heart failure significantly in mice with chronic high blood pressure. The finding provides new insight into the root causes of the progressive decline in cardiac function that is heart failure and suggests a novel method to prevent the deterioration.

DURHAM, N.C. -- By disrupting the activity of a single heart protein, Duke University Medical Center researchers eased heart failure significantly in mice with chronic high blood pressure. The finding provides new insight into the root causes of the progressive decline in cardiac function that is heart failure and suggests a novel method to prevent the deterioration.

Related Articles


"Despite newer therapies to treat heart failure, patient mortality rates remain high, indicating a need for novel treatment strategies that complement current methods," said Howard Rockman, M.D., professor of medicine and senior author of the study. "The current study elucidates a key cellular mechanism that underlies heart failure and identifies a promising new method for stalling the progression of the disease."

The team reports its findings in the October 2003 issue of The Journal of Clinical Investigation. The research was funded by the National Institutes of Health, the Burroughs Wellcome Fund and the Stanley J. Sarnoff Endowment for Cardiovascular Science.

The researchers studied beta-adrenergic receptors on the surface of heart cells, which modify the activity of the heart in response to the hormone adrenaline. These receptors -- protein switches that nestle in the cell membrane -- control the heart's ability to pump blood to the tissues of the body in response to such environmental situations as exercise or stress.

In heart failure patients, chronic stress leads to an excess of adrenaline, thereby over-stimulating beta-adrenergic receptors, a process that results in receptor desensitization and loss, Rockman said. Cardiologists have long debated whether the loss of beta-adrenergic receptors characteristic of heart failure protects the heart or whether it contributes to the disease, he added.

Earlier work conducted by Rockman's team identified a protein enzyme, called PI3Kgamma, which is required for the internalization and recycling of beta-adrenergic receptors on heart cells. Disrupting the function of PI3Kgamma preserves beta-adrenergic receptors on heart cells when they are chronically exposed to adrenaline, Rockman said.

However, whether the manipulation would maintain heart receptors in a living animal was unclear, as were the consequences of such an intervention for the failing heart. "If we prevent beta-adrenergic receptors from being internalized, what happens to heart function? Is it better or worse?" Rockman asked.

In the new study, the researchers genetically manipulated mice to produce an inactive form of PI3Kgamma, which shut down the protein's ability to trigger beta-adrenergic receptor loss. Thus, in the genetically altered mice, beta-adrenergic receptors remained active when chronically exposed to an adrenaline-like chemical, while the receptors of normal mice exhibited a substantial loss of function as occurs in heart failure patients, they found.

Moreover, after three months of chronic pressure overload, mice with the inactive heart protein exhibited less than half the decline in heart function compared to mice with the active protein, the team reported. The mutant mice with high blood pressure also survived longer than normal mice with the same condition.

"Our study results show that an intervention that maintains functional beta-adrenergic receptors on the heart surface by disrupting PI3Kgamma activity leads to improved heart function, a result supporting the idea that the loss of receptors contributes to heart failure," Rockman said. "These findings identify a potential new target for heart drugs and may have important clinical implications."

The research team included Jeffrey Nienaber, M.D., a surgical fellow and primary author of the study, Hideo Tachibana, M.D., Sathyamangla Naga Prasad, Ph.D., and Lan Mao, M.D., all of Duke. Other participants include Giovanni Esposito, M.D., of Federico II University in Naples, Italy and Dianqing Wu, Ph.D., of the University of Connecticut Health Center in Farmington.


Story Source:

The above story is based on materials provided by Duke University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Duke University Medical Center. "New Insight Into Heart Failure Suggests Novel Drug Target." ScienceDaily. ScienceDaily, 2 October 2003. <www.sciencedaily.com/releases/2003/10/031002055520.htm>.
Duke University Medical Center. (2003, October 2). New Insight Into Heart Failure Suggests Novel Drug Target. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2003/10/031002055520.htm
Duke University Medical Center. "New Insight Into Heart Failure Suggests Novel Drug Target." ScienceDaily. www.sciencedaily.com/releases/2003/10/031002055520.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins